Abstract [from journal]
In response to the coronavirus disease 2019 (COVID-19) pandemic many cardiac catheterization and electrophysiology laboratories canceled elective procedures to limit the burden on hospital resources. A major challenge in resuming elective procedures is the risk of exposing patients and health care personnel (HCP) to carriers of the virus. To facilitate procedure resumption, the Hospital of the University of Pennsylvania began testing all patients scheduled for elective and urgent catheterization and electrophysiology procedures for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on April 14, 2020. We report the results of testing for a 4-week period and describe results of patient and HCP surveys regarding their perceptions on universal testing.